NVYTF (Novacyt) Cyclically Adjusted PB Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NVYTF Novacyt SA NVYTF
34 GF Score
Price $0.57
GF Value $0.86
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Novacyt Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Novacyt  (OTCPK:NVYTF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Novacyt Cyclically Adjusted PB Ratio Related Terms


Novacyt Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Novacyt's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novacyt Cyclically Adjusted PB Ratio Chart

Novacyt Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.08 0.46 0.39 0.39 0.35

Novacyt Semi-Annual Data
Jun15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.34 0.39 0.33 0.35

NVYTF vs ABT, SYK, MDT: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Novacyt's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novacyt Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Novacyt's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Novacyt's Cyclically Adjusted PB Ratio falls into.


NVYTF
34GF Score
Novacyt SA NVYTF
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novacyt Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Novacyt's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec25 is calculated as:

For example, Novacyt's adjusted Book Value per Share data for the fiscal year that ended in Dec25 was:

Adj_Book=Book Value per Share/CPI of Dec25 (Change)*Current CPI (Dec25)
=0.445/120.8900*120.8900
=0.445

Current CPI (Dec25) = 120.8900.

Novacyt Annual Data

Book Value per Share CPI Adj_Book
201612 1.076 100.650 1.292
201712 0.794 101.850 0.942
201812 0.611 103.470 0.714
201912 0.284 104.980 0.327
202012 2.917 104.960 3.360
202112 2.720 107.850 3.049
202212 1.962 114.160 2.078
202312 1.575 118.390 1.608
202412 0.849 119.950 0.856
202512 0.445 120.890 0.445

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Novacyt (NVYTF) Overvalued in 2026?

Based on GuruFocus' analysis, Novacyt stock appears to be undervalued. The current stock price of $0.57 is trading 33.7% below its estimated GF Value™ of $0.86. GuruFocus considers Novacyt to be Possible Value Trap.

Key valuation signals for NVYTF:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $0.86 vs. price of $0.57 (33.7% below fair value)
  • GF Score™: 34/100 with 4 warning signs

No single metric tells the full story. See the NVYTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Novacyt Business Description

Address 131 Boulevard Carnot, Le Vesinet, FRA, 78110
Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments: Primer Design, Yourgene Health and Corporate. Majority of the revenue is generated from Yourgene Health segment. Geographically, the company operates in United Kingdom, France, Europe, America, Asia-Pacific, Middle East and Africa generating majority from Asia- pacific region.
34GF Score

Get the complete analysis for NVYTF

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.57
Price
$0.86
GF Value